Periodontal health and caries prevalence evaluation in patients affected by Parkinson's disease
- PMID: 23320249
- PMCID: PMC3539438
- DOI: 10.1155/2012/541908
Periodontal health and caries prevalence evaluation in patients affected by Parkinson's disease
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative disorder related to the loss or absence of dopaminergic neurons in the brain. These deficits result in slowness of movement, tremor, rigidity, and dysfunction of behaviour. These symptoms negatively influence the patient's capability to carry out the daily oral hygiene manoeuvres. The aim of this work is to record the oral health condition of PD patients evaluated at the IRCSS Bonino-Puleio in Messina. The oral health of 45 consecutive PD patients (study group) with neurologic diagnosis based on United Kingdom Brain Bank Criteria has been compared with that of another 45 no PD patients of the same age (control group). The evaluation of the general oral condition was recorded underlining tooth loss, active periodontal disease, and presence of untreated caries. The frequency of untreated caries, periodontal diseases, and missing teeth of the study group was significantly higher than in control group. Based on the data results, clinicians should direct high attention to the oral hygiene of patients with PD, above all at the early stages of the caries or periodontal disease, in order to prevent serious evolution of those pathologic dental conditions that may finally result in the tooth extraction event.
Figures







Similar articles
-
Clinical evaluation of the oral health status in vascular-type dementia patients. A case-control study.Minerva Stomatol. 2015 Aug;64(4):167-75. Minerva Stomatol. 2015. PMID: 25937578
-
Increased frequencies of caries, periodontal disease and tooth loss in patients with Parkinson's disease.J Clin Neurosci. 2009 Oct;16(10):1279-82. doi: 10.1016/j.jocn.2008.12.027. Epub 2009 Jun 30. J Clin Neurosci. 2009. PMID: 19570683
-
Caries and periodontal disease in patients with Parkinson's disease.Spec Care Dentist. 2011 Sep-Oct;31(5):178-81. doi: 10.1111/j.1754-4505.2011.00205.x. Spec Care Dentist. 2011. PMID: 21950532
-
Prevention and control of dental caries and periodontal diseases at individual and population level: consensus report of group 3 of joint EFP/ORCA workshop on the boundaries between caries and periodontal diseases.J Clin Periodontol. 2017 Mar;44 Suppl 18:S85-S93. doi: 10.1111/jcpe.12687. J Clin Periodontol. 2017. PMID: 28266120
-
Oral health and implant therapy in Parkinson's patients: review.Oral Implantol (Rome). 2017 Sep 27;10(2):105-111. doi: 10.11138/orl/2017.10.2.105. eCollection 2017 Apr-Jun. Oral Implantol (Rome). 2017. PMID: 29876035 Free PMC article. Review.
Cited by
-
Mineral Trioxide Aggregate Applications in Endodontics: A Review.Eur J Dent. 2020 Oct;14(4):683-691. doi: 10.1055/s-0040-1713073. Epub 2020 Jul 29. Eur J Dent. 2020. PMID: 32726858 Free PMC article.
-
Periodontal health in a population with Parkinson's disease in Spain: a cross-sectional study.Med Oral Patol Oral Cir Bucal. 2023 Jan 1;28(1):e32-e40. doi: 10.4317/medoral.25540. Med Oral Patol Oral Cir Bucal. 2023. PMID: 36243992 Free PMC article.
-
Facts and controversies regarding oral health in Parkinson's disease: A case-control study in Spanish patients.Med Oral Patol Oral Cir Bucal. 2022 Sep 1;27(5):e419-e425. doi: 10.4317/medoral.25348. Med Oral Patol Oral Cir Bucal. 2022. PMID: 35368008 Free PMC article.
-
Evaluation of the association between periodontitis and risk of Parkinson's disease: a nationwide retrospective cohort study.Sci Rep. 2021 Aug 16;11(1):16594. doi: 10.1038/s41598-021-96147-4. Sci Rep. 2021. PMID: 34400731 Free PMC article.
-
Chlorhexidine Gel Use in the Oral District: A Systematic Review.Gels. 2019 Jun 11;5(2):31. doi: 10.3390/gels5020031. Gels. 2019. PMID: 31212600 Free PMC article. Review.
References
-
- Obeso I, Wilkinson L, Casabona E, et al. Deficits in inhibitory control and conflict resolution on cognitive and motor tasks in Parkinson’s disease. Experimental Brain Research. 2011;212(3):371–384. - PubMed
-
- Brown RG, Marsden CD. How common is dementia in Parkinson’s disease? The Lancet. 1984;2(8414):1262–1265. - PubMed
-
- Olanow CW, Obeso JA. The significance of defining preclinical or prodromal Parkinson’s disease. Movement Disorders. 2012;27(5):666–669. - PubMed
-
- Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson’s disease. Neuroscience & Biobehavioral Reviews. 2006;30(1):1–23. - PubMed
-
- Owen AM. Cognitive dysfunction in Parkinson’s disease: the role of frontostriatal circuitry. Neuroscientist. 2004;10(6):525–537. - PubMed
LinkOut - more resources
Full Text Sources